21st Austria weekly - Marinomed, Austrian Post (18/12/2023)
21st Austria weekly - Marinomed Austrian Post 18/12/2023 [pic1]Marinomed: Marinomed Biotech AG considers strategic options for its Carragelose business and has mandated an external advisor. A structured process was initiated in which the advisor will start engaging with potential partners. This initiative meets attractive market environment those assets that comply new EU medical device regulation MDR. In May 2024 important interim period ends imposing challenging requirements all devices. Products don’t fulfil these lose their certificate must not be marketed. products necessary ...
Source: boerse-social.com
